Not applicableActive Not RecruitingNCT02414022What this trial is testingEconomic Analysis of Alliance A041202 CLL StudyWho this might be right forChronic Lymphocytic Leukemia Canadian Cancer Trials Group 55
Testing effectiveness (Phase 2)Study completedNCT01326702What this trial is testingVeliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01271283What this trial is testingLenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaStage III Chronic Lymphocytic LeukemiaStage IV Chronic Lymphocytic Leukemia National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003396What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)UnknownNCT02685670What this trial is testingCompetitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Large-scale testing (Phase 3)UnknownNCT00482716What this trial is testingEpoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+2 more St. Bartholomew's Hospital 80
Large-scale testing (Phase 3)Study completedNCT00046683What this trial is testingEfficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic LeukemiaWho this might be right forB Cell Chronic Lymphocytic Leukemia Genzyme, a Sanofi Company 284
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00275054What this trial is testingRituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 825
Testing effectiveness (Phase 2)Study completedNCT03097770What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20Who this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 100
Large-scale testing (Phase 3)Study completedNCT00931645What this trial is testingAutologous Stem Cell Transplantation in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia University Hospital, Caen 241
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)Study completedNCT00002766What this trial is testingComparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 170
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Early research (Phase 1)Study completedNCT00077155What this trial is testingCilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00004084What this trial is testingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Garden State Cancer Center at the Center for Molecular Medicine and Immunology 21
Large-scale testing (Phase 3)Looking for participantsNCT04269902What this trial is testingTesting Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma National Cancer Institute (NCI) 247
Testing effectiveness (Phase 2)Study completedNCT00089154What this trial is testingApolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forNoncontiguous Stage II Small Lymphocytic LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+2 more National Cancer Institute (NCI) 32